Navigation Links
OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008
Date:1/16/2009

FT. LAUDERDALE, Fla., Jan. 16 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture solutions for clinical trials, today announced record breaking results for 2008 in new and repeat business that exceeded original expectations. A record jump of 80% in contracts over 2007 clearly validates OmniComm's position as a major contender in the EDC Marketplace.

"OmniComm has worked hard to build a strong foundation of superior products and services for our customers," said Stephen Johnson, COO of OmniComm. "We recognize the importance of our clients' business and are working diligently to deliver the integrated solutions that they need to succeed. In the very near future, our plans include the introduction of our own IVRS tool, IVRMaster, that will seamlessly integrate with our EDC tool, TrialMaster(R) to offer randomization, ePRO and supply tracking. In early 2009, we will also be releasing our Clinical Data Hub product to offer a more centralized and seamless aggregation of clinical data across multiple systems. This solution will empower our clients to take better control of their data and better leverage core industry standards like CDISC/CDASH, e2b and SDTM."

Added CFO, Ronald Linares, "We are pleased that we were able to increase our revenues during 2008 during what was a difficult year in the macro- economy. More importantly, we have diversified our client mix to include larger Bio-tech firms and have successfully begun deploying our product on a licensed basis."

OmniComm continues to increase its customer base with a strong mix of new customer business coupled with steady, recurring business from its existing loyal customers. The following is a breakdown of business for 2008.

    Milestones for 2008:

    -- 60 New Business Deals Including:
        -- 4 Pharmaceutical Companies
        -- 20 Biotechnology Companies
            -- Including Top 10 Biotech
        -- 11 Medical Device Companies
        -- 7 Academic Institutions
        -- 14 Contract Research Organizations (CROs)
        -- 4 Consulting Projects
    -- Introduced eLearning tool in July of 2007. Over 250 site users have
       successfully completed TrialMaster eLearning certification since the
       initial launch. The company recently released TrialMaster eLearning
       version 1.1, which includes an additional 9 lessons and certification
       focused on training Site Monitors and internal sponsor personnel.
    -- 2 Technology Transitions and 1 Technology Transfer for EDC
    -- Increased employee headcount from 77 to 85 FTEs
    -- 28 CRO Preferred Program Partners
    -- Expanded European office to include help desk support in seven
       languages

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Chicago, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.


'/>"/>
SOURCE OmniComm Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
2. DAZ Systems, Inc. Thrives in the Clean Energy Industry
3. Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference
4. Avantis Medical Systems, Inc. Announces Key Leadership Appointments
5. CEOs Letter to Shareholders of Imaging Diagnostic Systems, Inc.
6. Concuity Announces Partnership with Financial Healthcare Systems, LLC
7. StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform
8. Solei Systems, Inc., Announces That the Company Is Now Publicly Traded
9. Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R)
10. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
11. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... launch of the Supplyframe Design Lab . Located in Pasadena, Calif., the ... future of how hardware projects are designed, built and brought to market. , ...
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
Breaking Biology Technology:
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):